Healthcare & Life Sciences
Gain Therapeutics
United Statesgaintherapeutics.com/
Gain Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Pre-IPO, 1 tracked investor.
Activepre-ipo
pre-ipo
Stage
1
Investors
About Gain Therapeutics
Gain Therapeutics is a company headquartered in the United States. Its most recent tracked round is Pre-IPO. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Gain Therapeutics develops allosteric small molecule therapeutics using AI-supported 3D structural biology and physics-based models, focusing on treatments for neurodegenerative diseases including GBA-linked Parkinson's disease, with its lead candidate GT-02287 currently in clinical trials.
Explore Gain Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.